Recent advances on smart glycoconjugate vaccines in infections and cancer Article

cited authors

  • Anderluh, Marko; Berti, Francesco; Bzducha-Wrobel, Anna; Chiodo, Fabrizio; Colombo, Cinzia; Compostella, Federica; Durlik, Katarzyna; Ferhati, Xhenti; Holmdahl, Rikard; Jovanovic, Dragana; Kaca, Wieslaw; Lay, Luigi; Marinovic-Cincovic, Milena; Marradi, Marco; Ozil, Musa; Polito, Laura; Reina, Jose Juan; Reis, Celso A; Sackstein, Robert; Silipo, Alba; Svajger, Urban; Vanek, Ondrej; Yamamoto, Fumiichiro; Richichi, Barbara; van Vliet, Sandra J

fiu authors

publication date

  • June 1, 2021

keywords

  • BROADLY NEUTRALIZING ANTIBODIES
  • Biochemistry & Molecular Biology
  • CARBOHYDRATE-BASED VACCINES
  • CLUSTERED TN-ANTIGEN
  • GOLD NANOPARTICLES
  • INFLUENZAE TYPE-B
  • Life Sciences & Biomedicine
  • N-LINKED GLYCOSYLATION
  • PROTEIN CONJUGATE VACCINE
  • ROBUST IMMUNE-RESPONSES
  • SYNTHETIC ANTITUMOR VACCINES
  • Science & Technology
  • TUMOR-ASSOCIATED ANTIGEN
  • cancer
  • glycosylation
  • immune system
  • infection
  • vaccination

Digital Object Identifier (DOI)